Picture of Susmed logo

4263 Susmed Share Price

0.000.00%
jp flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapFalling Star

Momentum

Relative Strength (%)
1m+8.43%
3m-28.5%
6m-71.02%
1yr-73.17%
Volume Change (%)
10d/3m-64.77%
Price vs... (%)
52w High-71.31%
50d MA-6.27%
200d MA-56.1%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.81
Price to Tang. Book1.81
Price to Free Cashflow41.94
Price to Sales11.94
EV to EBITDA75.45

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.83%
Return on Equity1.01%
Operating Margin5.52%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202430th Jun 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Susmed EPS forecast chart

Profile Summary

Susmed Inc is a Japan-based company mainly engaged in the digital therapeutics (DTx) development business. The Company operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.

Directors

    Last Annual
    June 30th, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    July 31st, 2015
    Public Since
    December 24th, 2021
    No. of Shareholders
    4,692
    No. of Employees
    33
    Sector
    Software & IT Services
    Industry
    Technology
    Exchange
    jp flag iconTokyo Stock Exchange
    Shares in Issue
    16,727,800

    4263 Share Price Performance

    Upcoming Events for 4263

    Q3 2024 Susmed Inc Earnings Release

    Dividend For 4263.T - 0.0000 JPY

    Similar to 4263

    Picture of Abeja logo

    Abeja

    jp flag iconTokyo Stock Exchange

    Picture of Access Co logo

    Access Co

    jp flag iconTokyo Stock Exchange

    Picture of Acmos logo

    Acmos

    jp flag iconTokyo Stock Exchange

    Picture of Adish Co logo

    Adish Co

    jp flag iconTokyo Stock Exchange

    Picture of Ad-Sol Nissin logo

    Ad-Sol Nissin

    jp flag iconTokyo Stock Exchange

    FAQ